Several studies have investigated serological markers including acute phase reactants, e.g., C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) [8], and inflammation modulators, e.g., matrix metalloproteinases (MMPs) [9], as potential predictors for RA development in UA. This evidence concerns the gene CRP and rheumatoid arthritis.